Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment-Reference-Cited by-同舟云学术

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment

Published:2014-02-07 Issue:8 Volume:120 Page:1263-1271
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Resnick Matthew J.¹²,Barocas Daniel A.¹,Morgans Alicia K.³,Phillips Sharon E.⁴,Chen Vivien W.⁵,Cooperberg Matthew R.⁶,Goodman Michael⁷,Greenfield Sheldon⁸,Hamilton Ann S.⁹,Hoffman Karen E.¹⁰,Kaplan Sherri H.¹¹,Paddock Lisa E.¹²,Stroup Antoinette M.¹³,Wu Xiao-Cheng⁵,Koyama Tatsuki⁴,Penson David F.¹²

Affiliation:

1. Department of Urologic Surgery; Vanderbilt University Medical Center; Nashville Tennessee

2. Geriatric Research Education and Clinical Center; Veterans Affairs Tennessee Valley Healthcare System; Nashville Tennessee

3. Department of Medical Oncology; Vanderbilt University Medical Center; Nashville Tennessee

4. Department of Biostatistics; Vanderbilt University Medical Center; Nashville Tennessee

5. Department of Epidemiology; Louisiana State University Health Sciences Center; New Orleans Louisiana

6. Department of Urology; University of California San Francisco Medical Center; San Francisco California

7. Department of Epidemiology; Rollins School of Public Health, Emory University; Atlanta Georgia

8. Center for Health Policy Research and Department of Medicine; University of California Irvine; Irvine California

9. Department of Preventive Medicine; Keck School of Medicine, University of Southern California; Los Angeles California

10. Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

11. Health Policy Research Institute, University of California Irvine; Irvine California

12. The New Jersey State Cancer Registry; Trenton New Jersey

13. Department of Epidemiology; Rutgers University; New Brunswick New Jersey

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Preliminary treatment considerations among men with newly diagnosed prostate cancer [serial online];Zeliadt;Am J Manag Care,2010

2. Why do men choose 1 treatment over another? A review of patient decision making for localized prostate cancer;Zeliadt;Cancer,2006

3. Treatment decisions for localized prostate cancer: asking men what's important;Holmboe;J Gen Intern Med,2000

4. Patient-focused decision-making in early-stage prostate cancer: insights from a cognitively based decision aid;Feldman-Stewart;Health Expect,2004

5. Quality of life and satisfaction with outcome among prostate-cancer survivors;Sanda;N Engl J Med,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics as a Key Factor in Prostate Cancer;Advanced Biology;2024-02-20

2. Decision Regret and Bother With the Addition of Androgen Deprivation Therapy to Definitive Radiation Treatment for Localized Prostate Cancer;Practical Radiation Oncology;2023-09

3. Patient-reported functional outcome measures and treatment choice for prostate cancer;BMC Urology;2022-11-05

4. Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): do younger patients have more to lose?;World Journal of Urology;2022-02-06

5. Impact of Age and Race on Health-Related Quality of Life Outcomes in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer;Urology;2021-08